Second Malaria Vaccine: The second is that the World Health Organization (WHO) has included vaccination against malaria to its roster of immunizations that meet certain requirements. The shot, R21/Matrix-M vaccination for malaria was suggested by the WHO as malaria therapy in October of 2023. After the RTS, S/AS01 vaccine, which received prequalification status in July 2022, the R21 vaccine is the second malaria vaccine that the WHO has prequalified.
Second Malaria Vaccine: What does being a prequalified vaccination entail?
According to material on the WHO’s official website, a vaccine is added to the WHO List of Prequalified Vaccines if it has completed a thorough examination of pertinent data, testing of samples, and WHO inspection of relevant manufacturing locations, and the result is positive.
Oxford University created the R21 vaccine, which is produced by Serum Institute of India.
“We applaud the prequalification of R21/Matrix-M, the second malaria vaccine advised for children in malaria endemic areas, as a significant advancement in global health today. This accomplishment highlights our unwavering dedication to eliminating malaria, which continues to be a deadly and debilitating disease for children. This is another step in the direction of giving those who have lived for far too long in terror of what malaria could do to their children a healthier, more resilient future. We are together in our quest for a world free of malaria, where all lives are protected from the threat of this illness, along with our partners.” Director of the WHO’s Department of Immunization, Dr. Kate O’Brien said.
Second Malaria Vaccine: 608 000 malaria-related fatalities were reported worldwide in 2022
“Malaria, a mosquito-borne illness, kills around half a million children annually in the African Region, where it disproportionately affects young people. According to the WHO, there were 608,000 malaria fatalities and an anticipated 249 million malaria cases worldwide in 2022 among 85 countries.
Through the bites of female Anopheles mosquitoes carrying the Plasmodium parasite, people can contract malaria, a potentially fatal viral disease. Plasmodium comes in various species, the most lethal of which is P. falciparum. After getting into the bloodstream from a bite, the parasites go to the liver where they develop and proliferate before returning to the bloodstream to infect red blood cells.
Malaria can cause serious complications, such as organ failure and death, if it is not treated. Symptoms include fever, chills, sweats, headache, and nausea. Tropical and subtropical areas are common places to find malaria, especially in sub-Saharan Africa, South Asia, and portions of Central and South America.
The use of insecticide-treated bed nets, antimalarial medications, and mosquito control initiatives are examples of preventive approaches. Blood testing is usually used to confirm the diagnosis. Antimalarial drugs are necessary for effective therapy, yet drug resistance is a developing issue. Global initiatives to lower the prevalence of this terrible disease and enhance general public health include the distribution of bed nets sprayed with insecticide and the creation of a malaria vaccine. – Second Malaria Vaccine